Hepatitis-B Surface Antigen (HBsAg) Powder Formulation: Process and Stability Assessment

By  

Current Drug Delivery, Vol. 4, Iss. 1, 2007-01 ,pp. : 57-67

Bentham Science Publishers

Access to resources Recommend Favorite

Formulation Optimization of Human Insulin Loaded Microspheres for Controlled Oral Delivery Using Response Surface Methodology

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 17, Iss. 2, 2017-09 ,pp. : 149-165

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibiting the Secretion of Hepatitis B Surface Antigen (HBsAg) to Treat Hepatitis B Infection- a Review

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 17, Iss. 1, 2017-03 ,pp. : 24-35

Bentham Science Publishers

Access to resources Recommend Favorite

Optimization of Chitosan Succinate and Chitosan Phthalate Microspheres for Oral Delivery of Insulin using Response Surface Methodology

By Ubaidulla Udhumansha   Khar R. K.   Ahmad F. J.   Tripathi Purnima  

Pharmaceutical Development and Technology, Vol. 14, Iss. 1, 2009-01 ,pp. : 96-105

Informa Healthcare

Access to resources Recommend Favorite

Development characterizations and evaluation of Poly(-ε-caprolactone)-based microspheres for hepatitis B surface antigen delivery

By Tomar Priti   Karwasara Vijai Singh   Dixit V. K.  

Pharmaceutical Development and Technology, Vol. 16, Iss. 5, 2011-10 ,pp. : 489-496

Informa Healthcare

Access to resources Recommend Favorite